VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BTMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BTMDbiote Corp.
$2.25$99M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBTMDPrice Target
BTMD logo

biote Corp. (BTMD) Price Target Analysis

Updated Jun 12, 2026
Analyst Rating: Buy
Based on 7 analysts

44.4% Below Target

BTMD trades 44.4% below Wall Street's consensus target of $3.25.

Current Price$2.25
Average Target$3.25
Target
Current
Low$2.50
Median$3.25
High$4.00

Analyst Target Range

Forward P/E8.0x
(Value)
PEG Ratio—
Implied Growth-34.8%
(Declining)
Analyst Spread46.2%
(Moderate)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$2.25
Consensus$3.25
High$4.00
Low$2.50

Consensus Scenario Assumptions

The base valuation assumes BTMD achieves its forward estimates and maintains a stable P/E multiple of 8.0x. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 7 published analyst recommendations for BTMD

6/7 analysts are bullish
+43
BearishBullish
Weighted analyst sentiment score based on 7 ratings
ConsensusBuy
Coverage7 Analysts
Net Score+43
Bull / Bear86% / 0%
Strong Buy00%
Buy686%
Hold114%
Sell00%
Strong Sell00%
Strong Buy
00%
Buy
686%
Hold
114%
Sell
00%
Strong Sell
00%
Recommendation Mix86% Buy · 14% Hold · 0% Sell
Buy (6)Hold (1)Sell (0)

BTMD Price Target Analysis

Updated July 8, 2026

As of July 8, 2026, biote Corp. (BTMD) has a Wall Street consensus price target of $3.25, based on estimates from 7 covering analysts. With the stock currently trading at $2.25, this represents a potential upside of +44.4%. The company has a market capitalization of $99M.

Analyst price targets range from a low of $2.50 to a high of $4.00, representing a 46% spread in expectations. The median target of $3.25 aligns closely with the consensus average.

The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.

From a valuation perspective, BTMD trades at a trailing P/E of 3.0x and forward P/E of 8.0x. Analysts expect EPS to grow -34.8% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $1.71, with bear and bull scenarios of $1.08 and $2.25 respectively. Model confidence stands at 52/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+25.8%
Industry Consensus
Avg Forward P/E
40.2x
(Growth Premium)
Peers with Coverage
9 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
HIMS logo
HIMSHims & Hers Health, Inc.
$7.9B$36.17$28.69
-20.7%
Hold—20
EVAX logo
EVAXEvaxion Biotech A/S
$21M$3.31—————
AMWL logo
AMWLAmerican Well Corporation
$150M$8.99$6.33
-29.6%
Hold—15
NUVB logo
NUVBNuvation Bio Inc.
$2.0B$5.67$13.00
+129.3%
Buy—9
GDRX logo
GDRXGoodRx Holdings, Inc.
$1.1B$3.03$3.08
+1.7%
Hold9.8x24
DOCS logo
DOCSDoximity, Inc.
$4.3B$22.74$29.47
+29.6%
Hold15.9x23
ABBV logo
ABBVAbbVie Inc.
$449.9B$254.65$258.00
+1.3%
Buy17.9x41
AVDL logo
AVDLAvadel Pharmaceuticals plc
$2.1B$21.64$21.43
-1.0%
Buy28.3x14
TLRY logo
TLRYTilray Brands, Inc.
$502M$4.31$10.00
+132.0%
Hold—20
CLOV logo
CLOVClover Health Investments, Corp.
$2.6B$5.00$4.47
-10.6%
Hold129.2x9

BTMD — Frequently Asked Questions

Quick answers to the most common questions about buying BTMD stock.

What is the BTMD stock price target for 2026?

The consensus Wall Street price target for BTMD is $3.25, representing 44.4% upside from the current price of $2.25. With 7 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is BTMD a buy, sell, or hold?

BTMD has a consensus rating of "Buy" based on 7 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $3.25 implies 44.4% upside from current levels.

Is BTMD stock overvalued or undervalued?

With a forward P/E of 7.9646x, BTMD trades at a relatively low valuation. The consensus target of $3.25 implies 44.4% appreciation, suggesting meaningful undervaluation.

How high can BTMD stock go?

The most bullish Wall Street analyst has a price target of $4 for BTMD, while the most conservative target is $2.5. The consensus of $3.25 represents the median expectation. Our quantitative valuation model projects a bull case target of $2 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover BTMD stock?

BTMD is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the BTMD stock forecast?

The 12-month BTMD stock forecast based on 7 Wall Street analysts shows a consensus price target of $3.25, with estimates ranging from $2.5 (bear case) to $4 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $2, with bear/bull scenarios of $1/$2.

What is BTMD's fair value based on fundamentals?

Our quantitative valuation model calculates BTMD's fair value at $2 (base case), with a bear case of $1 and bull case of $2. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 52/100.

What is BTMD's forward P/E ratio?

BTMD trades at a forward P/E ratio of 8.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 3.0x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy BTMD stock?

Wall Street analysts are very optimistic on BTMD, with a "Buy" consensus rating and $3.25 price target (44.4% upside). 6 of 7 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do BTMD price targets vary so much?

BTMD analyst price targets range from $2.5 to $4, a 46% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $3.25 consensus represents the middle ground. Our model's $1-$2 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare